Cargando…
Metabolite Profiling and Characterization of LW6, a Novel HIF-1α Inhibitor, as an Antitumor Drug Candidate in Mice
A novel HIF (hypoxia-inducible factor)-1α inhibitor, the (aryloxyacetylamino)benzoic acid derivative LW6, is an anticancer agent that inhibits the accumulation of HIF-1α. The aim of this study was to characterize and determine the structures of the metabolites of LW6 in ICR mice. Metabolite identifi...
Autores principales: | Lee, Kiho, Lee, Ji-Yoon, Lee, Kyeong, Jung, Cho-Rock, Kim, Min-Ju, Kim, Jung-Ah, Yoo, Dong-Gu, Shin, Eun-Jin, Oh, Soo-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037336/ https://www.ncbi.nlm.nih.gov/pubmed/33808438 http://dx.doi.org/10.3390/molecules26071951 |
Ejemplares similares
-
Pharmacokinetic Characterization of LW6, a Novel Hypoxia-Inducible Factor-1α (HIF-1α) Inhibitor in Mice
por: Lee, Ji-Yoon, et al.
Publicado: (2021) -
The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation
por: Kim, Inhyub, et al.
Publicado: (2020) -
NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells
por: Lee, Sujin, et al.
Publicado: (2019) -
LW1497, an Inhibitor of Malate Dehydrogenase, Suppresses TGF-β1-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells by Downregulating Slug
por: Kim, Hyun Ji, et al.
Publicado: (2021)